Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Terminated × Everolimus × Clear all

Phase

Phase 2 42 Phase 1 19 Phase 1/2 12 Phase 3 4 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1

Status

Completed 10 Unknown 1 Terminated 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Sodium Chloride 4 Saline Solution 4 Pregabalin 4 Ketamine 4 Fentanyl 4 Bevacizumab 4 Tranexamic Acid 3 Photochemotherapy 3 Metformin 3 Letrozole 3 Docetaxel 3 Cyclophosphamide 3 ulipristal acetate 2 sodium glycididazole 2 nilotinib 2 liposomal doxorubicin 2 human papillomavirus vaccine, L1 type 16, 18 2 fludarabine 2 fluciclovine F-18 2 epoetin beta 2 aldesleukin 2 Trastuzumab 2 Surveys and Questionnaires 2 Sorafenib 2 Sofosbuvir 2 Rituximab 2 Ribavirin 2 Pemetrexed 2 Paclitaxel 2 Methotrexate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02338570 2018-02-05

ORCHIDEE

Mario Negri Institute for Pharmacological Research

Phase 4 Terminated

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡